XML 138 R105.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Reporting - Schedule of Business Segment Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]      
Revenue $ 174,432 $ 106,340 $ 97,948
Cost of revenue 90,170 55,890 60,897
Operating Expenses 259,498 127,050 153,256
Loss from operations (175,236) (76,600) (116,205)
Restructuring and related charges 12,500 7,076 9,732
Transaction and integration expenses 27,979 6,485 3,857
Operating segments      
Segment Reporting Information [Line Items]      
Loss from operations (58,697) (21,514) (53,000)
Corporate expenses      
Segment Reporting Information [Line Items]      
Loss from operations 76,060 41,525 49,616
Restructuring and related charges 12,500 5,352 7,096
Proteomics      
Segment Reporting Information [Line Items]      
Depreciation and amortization 9,198 12,072 12,223
Proteomics | Operating segments      
Segment Reporting Information [Line Items]      
Revenue 135,789 63,883 52,502
Cost of revenue 73,992 37,644 32,461
Operating Expenses 123,692 47,647 47,429
Loss from operations (61,895) (21,408) (27,388)
Restructuring and related charges 0 1,010 1,363
Genomics      
Segment Reporting Information [Line Items]      
Depreciation and amortization 1,486 601 230
Genomics | Operating segments      
Segment Reporting Information [Line Items]      
Revenue 38,643 42,457 45,446
Cost of revenue 16,178 18,246 28,436
Operating Expenses 19,267 24,317 42,622
Loss from operations 3,198 (106) (25,612)
Restructuring and related charges $ 0 $ 714 $ 1,273